Literature DB >> 16831980

Open-label extension studies and misinformation.

Lon S Schneider.   

Abstract

Mesh：

Year:  2006        PMID： 16831980     DOI： 10.1001/archneur.63.7.1036-a

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  3 in total

Review 1.  Open-label extension studies: do they provide meaningful information on the safety of new drugs?

Authors:  Richard O Day; Kenneth M Williams
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 2.  Long-term efficacy and toxicity of cholinesterase inhibitors in the treatment of Alzheimer disease.

Authors:  David B Hogan
Journal:  Can J Psychiatry       Date:  2014-12       Impact factor: 4.356

3.  Reliability in long-term clinical studies of disease-modifying therapies for relapsing-remitting multiple sclerosis: A systematic review.

Authors:  Rosa C Lucchetta; Letícia P Leonart; Marcus V M Gonçalves; Jefferson Becker; Roberto Pontarolo; Fernando Fernandez-Llimós; Astrid Wiens
Journal:  PLoS One       Date:  2020-06-16       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.